Definitive Contract W91YU005H0002

<p>This is a $9,744,757.04 Firm Fixed Price definitive contract awarded by the Defense Health Agency to Vascular Solutions LLC, a division of Teleflex Medical, for &quot;Freeze Dried Plasma Commercial Viability Activities&quot;. The contract has an ultimate completion date of September 30, 2025 and was awarded on September 9, 2020. The place of performance is Maple Grove, Minnesota. This contract does not have a set-aside designation.</p>

This is a federal contract award from the U.S. Special Operations Command (USSOCOM) to Terumo BCT Biotechnologies, LLC, a manufacturer of goods, for the production of a pre-production freeze-dried plasma product. The contract is a definitive, cost-plus-fixed-fee contract with a ceiling value of $20,135,723.26 and an ultimate completion date of September 30, 2021. The contract does not have a set-aside designation. As the prime contractor, Terumo BCT Biotechnologies, LLC will be responsible for...

This federal contract award, number SPE2DP24P0460, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi that specializes in blood collection, separation, storage, and transfusion products and services. The $10,300.80 firm-fixed-price purchase order is for the delivery of washing solution, which is likely to support transfusion medicine and cell therapy applications for the Department of Defense and other federal agencies....

The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price purchase order to Fenwal, Inc., a Fresenius Kabi company, for the delivery of Diluting Solution, F. The $3,621.60 contract has a completion date of March 12, 2024. Fenwal, Inc. is a global blood technology company that has an extensive history of providing blood collection, separation, storage, and transfusion products and services to various federal agencies. The company has supported the U.S. military's frozen...

This federal contract award is to Fenwal, Inc., a global blood technology company, for the provision of a variety of blood collection, processing, and transfusion-related products and services. The contract, valued at $22,800.00, was awarded by the Office of the Chief Operating Officer and does not have a set-aside designation. Fenwal, a subsidiary of Fresenius Kabi, is a registered federal vendor that has supplied items such as blood bags, tubing, solutions, apheresis equipment, and...

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of blood pack units with anticoagulant, with a ceiling value of $1,101.28 and a completion date of June 30, 2025. Fenwal, Inc. is a global blood technology company and a registered vendor with the U.S. federal government, providing specialized medical equipment and consumables to support...

This federal contract award, with ID SPE2DP23P0467, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $3,510.90 firm fixed-price purchase order is for the supply of washing solution, a specialized medical product used in healthcare and biomedical research initiatives. The contract has no set-aside designation and supports critical defense medical supply chains. Fenwal, Inc. is...

This is a delivery order awarded by the Veterans Integrated Service Network 9 (VISN 9), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. for the provision of emergency Privigen, a plasma-derived therapy. The delivery order, valued at $77,460.24, was issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which has a ceiling value of $201,482,280 and is valid through September 2026. The...

This is a firm fixed price (FFP) purchase order awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products and equipment. The $220,180.33 contract has a base period plus three one-year option periods to provide the following deliveries annually: 60 cases of 12% sodium chloride solution, 1 case of Sepacell pre-storage leukocyte reduction products, 88 cases of Amicus apheresis kits, and 24 cases of Intersol solution. The requirement had...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price purchase order to Cone Bioproducts of Seguin, LLC, a self-certified small disadvantaged business, to provide defibrinated plasma from vaccinated subjects. The contract has a potential value of $230,210.55 and a completion date of December 30, 2022. The requirement stems from an urgent need to source and convert plasma from COVID-19-naive individuals who have been...